CIK 0001907108
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Lexeo Therapeutics, Inc.
Sign in to watch- Ticker
- LXEO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 854012572
- Phone
- +1 212-547-9879
- Business address
- 345 PARK AVENUE SOUTH, FLOOR 6, NEW YORK, NY, 10010
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $18,214
- in 3 filings
Net −$18,214. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-11-07 | Omega Fund VI, L.P. 10% owner | Conversion | +1,415,865 | 1,415,865 | ||
| 2023-11-07 | Omega Fund VI, L.P. 10% owner | Conversion | +287,213 | 1,703,078 | ||
| 2023-11-07 | Omega Fund VI, L.P. 10% owner | Purchase | +454,545 | $11.00 | $5.0M | 2,157,623 |
| 2023-11-07 | Omega Fund VI, L.P. 10% owner | Conversion · Series A convertible preferred stock | −14,999,999 | 0 | ||
| 2023-11-07 | Omega Fund VI, L.P. 10% owner | Conversion · Series B convertible preferred stock | −2,615,533 | 0 |
Page 1 of 1 · 5 trades